Show simple item record

dc.date.accessioned 2021-10-28T15:47:53Z
dc.date.available 2021-10-28T15:47:53Z
dc.identifier.uri https://digital.cic.gba.gob.ar/handle/11746/11349
dc.title B-Chronic Lymphocytic Leukemia Autophagyc Cell Death by the Use of Manganese Doped Zinc Oxide Nanoparticles and Photo-Dynamic Therapy en
dc.type Artículo es
dcterms.abstract B-Chronic Lymphocytic Leukemia (B-CLL) usually follows an adverse, relentless clinical course by slowly developing drug resistance to fludarabine and other chemotherapeutic agents, as well as by acquiring new different genetic abnormalities. As B-CLL cells spontaneously produce high amounts of Reactive Oxygen Species (ROS) having an altered redox state in relation to that of normal B lymphocytes, we decided to probe different metal Zinc nanoparticles (ZnNPs) and quantify the levels of Singlet Oxigen (SO) to see if variations of its intracellular concentrations could execute and accelerate deadly programs in leukemic cells rather than in normal B lymphocytes, when applied with Photodynamic Therapy (PDT). In this way, we developed and tested a variety of metal ZnNPs of which one made of 0.5% Manganese Doped Zinc Oxide (ZnO:Mn) was finally selected for further testing as it had the best fludarabine resistant B-CLL cells in vitro killing activity, specially when combined with PDT. An interesting and rapidly dying process of B-CLL cells, known as autophagy, was always seen under Transmission Electronic Microscopy (TEM) when incubated with these 0.5% Mn doped ZnO NPs. This phenomenon correlated well with those intracellular increases of SO when PDT was administered, and measured by a novel method first described by us. As this therapy seems to be very specific to fludarabine resistant B-CLL cells, producing almost no damage to normal lymphocytes, it could surely contribute in the near future as a new innovative targeted strategy to be delivered in the clinical setting for the definitive benefit of these bad prognostic patients. en
dcterms.extent 15-25 es
dcterms.issued 2014
dcterms.language Inglés es
dcterms.license Attribution 4.0 International (BY 4.0) es
dcterms.subject B-Chronic Lymphocytic Leukemia en
dcterms.subject Metal ZnNPs en
cic.version info:eu-repo/semantics/publishedVersion es
dcterms.creator.author Peña Luengas, Sandra es
dcterms.creator.author Marín, Gustavo H. es
dcterms.creator.author Rodriguez Nieto, Felipe Jorge es
dcterms.creator.author Dreon, Marcos Sebastián es
dcterms.creator.author Roque, Gustavo es
dcterms.creator.author Núñez, Luis es
dcterms.creator.author Sánchez, Fransisco es
dcterms.creator.author Tarditti, Adrián es
dcterms.creator.author Schinella, Guillermo Raúl es
dcterms.creator.author Pistaccio, Luis es
dcterms.creator.author Goya, Rodolfo es
dcterms.creator.author Tau, Jose Maria es
dcterms.creator.author Ichim, Thomas es
dcterms.creator.author Riordan, Neil es
dcterms.creator.author Rivera Montalvo, Luis es
dcterms.creator.author Mansilla, Eduardo es
cic.lugarDesarrollo Universidad Nacional de La Plata es
dcterms.subject.materia Ciencias Químicas es
dcterms.subject.materia Ciencias Médicas es
dcterms.identifier.url Recurso online es
dcterms.identifier.other ISSN: 0975 4415 es
dcterms.isPartOf.issue vol. 5, no. 1 es
dcterms.isPartOf.series International Journal of Drug Delivery Technology es
cic.isPeerReviewed true es
cic.isFulltext true es


Files

  • Icon

    Documento completo 

    PDF file (949.7Kb)

  • This item appears in the following Collection(s)

    Show simple item record